论文部分内容阅读
目的：探讨子宫内膜癌的疗效从其预后因素。方法;收集1979年4月至1991年4月随访资料完整的182例子宫内膜癌。全组病人均经手术及术前放疗，部分病人术后放疗。经统计学X2检验分析预后。结果：总5年生存率80.2％，Ⅰ期91.9％，Ⅱ期81％，Ⅲ期56％，Ⅳ期0，临床分期、病理类型、组织学分级、宫体肌层浸润盆腔淋巴结转移是影响预后的重要因素、结论;术前分段诊刮至关重要、放宽1期病例下术指征是提高Ⅰ期盆腔淋巴结转移病例存活率的关键，术前术后放疗是防止复发提高存活率的有效措施。
Objective: To investigate the efficacy of endometrial cancer from its prognostic factors. Methods A total of 182 cases of endometrial cancer with complete follow-up data from April 1979 to April 1991 were collected. All patients were treated by surgery and preoperative radiotherapy, some patients after radiotherapy. The statistical analysis of X2 test prognosis. Results: The overall 5-year survival rate was 80.2%, stage Ⅰ 91.9%, stage Ⅱ 81%, stage Ⅲ 56%, stage Ⅳ 0, clinical stage, pathological type, histological grade, myometrial invasion and pelvic lymph node metastasis were prognostic factors Of the important factors, the conclusion; preoperative segmental curettage is essential to relax a case of operation instructions is to improve the survival of patients with stage Ⅰ pelvic lymph node metastasis of key, preoperative and postoperative radiotherapy is to prevent recurrence to improve the survival rate of effective Measures.